Jacobson, I.R., Dore, G.J., Foster, G.R., Fried, M.W., Radu, M., Rafalsky, V.V., et al. (2014). Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. THE LANCET, 384(9941), 403-413 [10.1016/S0140-6736(14)60494-3].

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

CRAXI, Antonio;
2014-01-01

2014
Jacobson, I.R., Dore, G.J., Foster, G.R., Fried, M.W., Radu, M., Rafalsky, V.V., et al. (2014). Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. THE LANCET, 384(9941), 403-413 [10.1016/S0140-6736(14)60494-3].
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0140673614604943-main.pdf

Solo gestori archvio

Dimensione 282.27 kB
Formato Adobe PDF
282.27 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/99286
Citazioni
  • ???jsp.display-item.citation.pmc??? 150
  • Scopus 322
  • ???jsp.display-item.citation.isi??? 353
social impact